Clinical Trial

The Effect of Intravenous Dexketoprofen on the Severity and Incidence of Rebound Pain

Recruiting
View on ClinicalTrials.gov →
Summary
Orthopedic shoulder surgeries are associated with severe postoperative pain, particularly within the first 24-48 hours after surgery. In postoperative pain management, single or continue interscalene brachial plexus blocks, acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), and opioids administered as needed are commonly used as components of multimodal analgesia. Rebound pain is defined as severe postoperative pain (VAS ≥ 7) occurring within the first 24 hours after resolution of the block. It is considered an adverse effect of regional anesthesia and typically develops 8-12 hours after a single-shot nerve block. Risk factors for rebound pain include pre-existing pain, female sex, younger age, bone surgery, lack of intraoperative dexamethasone administration, and inadequate analgesia. The primary objective of this study is to evaluate the effect of intravenous dexketoprofen administered during the postoperative period on the incidence and severity of rebound pain in patients undergoing shoulder surgery with interscalene brachial plexus block
Protocol Amendment History 3 changes
critical Recruitment opened 2026-06-13
notable Primary completion pushed: 2026-10-30 -> 2027-01-01 2026-06-13
minor Completion pushed: 2026-10-30 -> 2027-01-01 2026-06-13
Trial Details
NCT Number NCT07642674
Lead Sponsor Eskisehir Osmangazi University
Conditions Postoperative Pain, Pain Management, Rebound Pain, Interscalene Block
Enrollment 66 participants
Start Date 2026-06-11
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-06-12